Q2 2025 agilon health inc Earnings Call Transcript

Aug 4, 2025 / 09:30 PM GMT

Release Date Price: $45.38 (+6.76%)

Transcript 10-Q8-K

Key Points

Positve

Agilon Health Inc (AGL) is actively pursuing strategic initiatives to improve contract economics, reduce risk, and optimize cost structure, which are expected to enhance performance in 2026.
The company has significantly improved data visibility and timeliness, with 72% of the patient population validated in the enhanced data platform, increasing confidence in future performance.
Agilon Health Inc (AGL) has a strong quality program, with year two plus markets achieving quality scores at or above 4.25 stars, which is a strength in negotiations with payers.
The company is focused on enhancing its platform through advancements in technology, clinical pathways, and operating efficiency, aiming to drive higher quality care and reduce variability.
Agilon Health Inc (AGL) has reduced its exposure to Medicare Part D, with less than 30% of membership carrying Part D risk in 2025, and continues to make progress in reducing it further for 2026.

Negative

Agilon Health Inc (AGL) reported underperformance due to lower than expected risk adjustment contributions for both 2024 and 2025, impacting financial results.
The company withdrew its 2025 guidance due to market uncertainties and execution challenges, indicating a lack of confidence in near-term financial projections.
Agilon Health Inc (AGL) experienced a decrease in Medicare Advantage membership, from 513,000 members in Q2 2024 to 498,000 members in Q2 2025, reflecting market exits and a measured approach to growth.
The company's medical margin for Q2 2025 was negative $53 million, compared to a positive $106 million in Q2 2024, primarily due to underperformance in the burden of illness program.
Agilon Health Inc (AGL) is facing industry complexities and headwinds that are more acute than previously expected, affecting execution and financial performance.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

AGL.N - agilon health Inc
Q2 2025 agilon health inc Earnings Call
Aug 04, 2025 / 09:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon and thank you for attending the Agilon Health Second quarter 2025 conference call. My name is Jay Song. I'll be the moderator today. All lines will be muted during the presentation portion of the call with an opportunity for questions and answers at the end.

And now like to pass the conference over to your host Evan Smith.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, operator. Good afternoon and welcome to the call. With me are Ron Williams, our executive chair, and our CFO Jeff Schwanke. Following our prepared remarks, we will conduct a Q&A

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.